Waters Corporation (WAT)

Currency in USD
281.20
+3.20(+1.15%)
Closed·
After Hours
285.00+3.80(+1.35%)
·
WAT Scorecard
Full Analysis
8 analysts have revised their earnings downwards for the upcoming period
Trading near 52-week Low
WAT is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
275.05281.20
52 wk Range
275.05423.56
Key Statistics
Prev. Close
278
Open
277.69
Day's Range
275.05-281.2
52 wk Range
275.05-423.56
Volume
789.18K
Average Volume (3m)
750.28K
1-Year Change
-15.48%
Book Value / Share
36.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
357.41
Upside
+27.10%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Waters Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Waters Corporation Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation SWOT Analysis


Biotech Boom Catalyst
Waters Corporation poised for growth as a key player in the expanding biotechnology and pharmaceutical sectors, with strategic positioning in high-demand areas
Financial Robustness
Explore Waters' strong financial performance, including a 59.27% gross profit margin and revenue growth of 2.57%, underpinning its market confidence
Strategic Acquisitions
Delve into Waters' strategic moves, including the Halo Labs and Wyatt Technology acquisitions, enhancing its biologics capabilities and market position
Analyst Optimism
Learn about analyst projections for Waters, with price targets ranging from $343.11 to $460.00, reflecting confidence in the company's growth trajectory
Read full SWOT analysis

Waters Corporation Earnings Call Summary for Q2/2025

  • Waters Q2 2025 EPS of $2.95 beat forecast, revenue of $771M exceeded expectations by $22.96M
  • Stock dipped 0.11% despite positive earnings; company trades at P/E ratio of 26.08
  • Full-year EPS guidance raised to $12.95-$13.05, constant currency sales growth forecast up to 5.5%-7.5%
  • Pharma segment saw double-digit growth, industrial segment up 6%, recurring revenue increased 11%
  • CEO highlighted strong quarter, strategic positioning with 80% revenue from leading brands, 70% annual recurring base
Last Updated: 04/08/2025, 14:28
Read Full Transcript

Compare WAT to Peers and Sector

Metrics to compare
WAT
Peers
Sector
Relationship
P/E Ratio
25.3x5.6x−0.5x
PEG Ratio
2.350.010.00
Price/Book
7.7x1.0x2.6x
Price / LTM Sales
5.5x1.5x3.3x
Upside (Analyst Target)
21.6%47.4%43.3%
Fair Value Upside
Unlock29.6%6.9%Unlock

Analyst Ratings

6 Buy
12 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 357.41
(+27.10% Upside)

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
2.95 / 2.94
Revenue / Forecast
771.00M / 748.04M
EPS Revisions
Last 90 days

WAT Income Statement

People Also Watch

25.59
CNC
+1.31%
156.90
MOH
+1.23%
842.50
AXON
-3.27%
293.99
ELV
+3.71%
133.24
FI
+0.41%

FAQ

What Stock Exchange Does Waters Trade On?

Waters is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Waters?

The stock symbol for Waters is "WAT."

What Is the Waters Market Cap?

As of today, Waters market cap is 16.74B.

What Is Waters's Earnings Per Share (TTM)?

The Waters EPS (TTM) is 11.13.

When Is the Next Waters Earnings Date?

Waters will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is WAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Waters Stock Split?

Waters has split 2 times.

How Many Employees Does Waters Have?

Waters has 7600 employees.

What is the current trading status of Waters (WAT)?

As of 11 Aug 2025, Waters (WAT) is trading at a price of 281.20, with a previous close of 278.00. The stock has fluctuated within a day range of 275.05 to 281.20, while its 52-week range spans from 275.05 to 423.56.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.